Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
UBS
Boehringer Ingelheim
Queensland Health
Citi
Dow
Colorcon
AstraZeneca
QuintilesIMS
Baxter

Generated: August 19, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title:2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
Abstract: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, ##STR00001## wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
Inventor(s): Differding; Edmond (Louvain-la-Neuve, BE), Kenda; Beno t (Emines, BE), Lallemand; Benedicte (Waimes, BE), Matagne; Alain (Gerpinnes, BE), Michel; Philippe (Beersel, BE), Pasau; Patrick (Chastre, BE), Talaga; Patrice (Watermael-Boitsfort, BE)
Assignee: UCB, S.A. (Brussels, BE)
Filing Date:Jan 27, 2005
Application Number:11/043,176
Claims:1. A compound of formula AA-II, or a pharmaceutically acceptable salt thereof: ##STR00072## wherein X is --CA.sup.1NR.sup.5R.sup.6 or --CA.sup.1--R.sup.8; A.sup.1 is oxygen, sulfur or --NR.sup.9; Q.sup.1 together with the oxygen to which it is attached is a leaving group; R.sup.1 is hydrogen, alkyl, aryl or --CH.sub.2--R.sup.1a wherein R.sup.1a is aryl, halogen, hydroxy, amino, nitro or cyano; R.sup.3 is hydrogen, halogen, thiol, nitro, nitrooxy, cyano, azido, carboxy, amido, sulfonic acid, sulfonamide, alkyl, alkcenyl, alkynyl, ester, ether, aryl, tetrazolyl, thiazolyl, thienyl, furyl, pyrrolyl, pyridinyl, alkynyloxy, acyloxy, oxyester, oxyamido, alkylsulfonyloxy, alkylsulfinyloxy, arylsulfonyloxy, arylsulfinyloxy, aryloxy, aralkoxy, alkylthio, alkenylthio, alkynylthio, arylthio, formyl, acetyl, propionyl, isobutyryl, valeryl, lauroyl, heptanedioyl, cyclohexanecarbonyl, crotonoyl, furmaroyl, acyloyl, benzoyl, naphtoyl, 4-carboxybutanoyl, oxalyl, ethoxalyl, cysteinyl, oxamoyl, alkylsulfonyl, alkenylsulfonyl, alkynylsulfonyl, arylsulfonyl, alkylsulfinyl, alkenylsulfinyl, alkynylsulfinyl or arylsulfinyl; R.sup.3a is hydrogen, halogen, alkyl, alkenyl, alkynyl or aryl; R.sup.5, R.sup.6 and R.sup.9 are the same or different and each is independently hydrogen, hydroxy, alkyl, aryl, alkoxy, alkenyloxy, alkynyloxy, acyloxy, oxyester, oxyamido, alkylsulfonyloxy, alkylsulfinyloxy, arylsulfonyloxy, arylsulfinyloxy, aryloxy or arylakoxy; and R.sup.8 is hydrogen, hydroxy, thiol, halogen, alkyl, aryl, alkylthio, alkenylthio or alkynylthio; with the provisos that at least one of R.sup.3 and R.sup.3a is other than hydrogen; and that when the compound is a mixture of all possible stereoisomers, X is --CONR.sup.5R.sup.6 and R.sup.1 is hydrogen, methyl, ethyl or propyl then R.sup.3 and R.sup.3a substitution on the pyrrolidine ring is other than mono-, di-methyl or mono-ethyl; and that when R.sup.1 and R.sup.3a are both hydrogen and X is --CONR.sup.5R.sup.6 then R.sup.3 is different from carboxy, ester, amido, substituted oxo-pyrrolidine, alkynyloxy, acyloxy, oxyester, oxyamido, alkylsulfonyloxy, alkylsulfinyloxy, arylsulfonyloxy, arylsulfinyloxy, aryloxy, aralkoxy, methyl, naphtyl, phenyl optionally substituted by oxy derivatives or in the para position by an halogen atom.

2. A compound according to claim 1, or a pharmaceutically acceptable salt thereof, wherein Q.sup.1 is a substituent group selected from a) alkyl; or b) linear or branched C.sub.1-4-alkyl.

3. A compound according to claim 1, or a pharmaceutically acceptable salt thereof, which is a pure enantiomer.

4. A compound according to claim 1, or a pharmaceutically acceptable salt thereof, wherein, when the carbon atom to which R.sup.1 is attached is asymmetric, said carbon atom is in the "S"-configuration.

5. A compound according to claim 1, or a pharmaceutically acceptable salt thereof, which is at least one enantiomer, at least one diastereomer, or a mixture thereof.

6. A composition comprising the compound according to claim 1, or a pharmaceutically acceptable salt thereof, and a diluent or pharmaceutically acceptable carrier.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Cerilliant
Boehringer Ingelheim
Novartis
McKesson
Federal Trade Commission
AstraZeneca
Citi
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot